Secretome Therapeutics logo

Secretome Therapeutics

Recent Finacing

Series A

Recent Raise

$30M

Secretome Therapeutics is a clinical-stage biotechnology company developing therapies derived from neonatal cardiac progenitor cells.

Founded 2018
Texas, United States
11-50
Private
secretometherapeutics.com
PitchBook

Highlights

Focus Areas

Biotechnology
Health Care
Medical
Therapeutics

Recent Investors

RA Capital Management logo
HEST Investments logo

Financials

$52.2M

Total Raised

3

Funding rounds

1

Investor

Team

Upgrade to view the team

See the team members at Secretome Therapeutics.